Andrew B Nixon
Duke University
H-index: 37
North America-United States
Top articles of Andrew B Nixon
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies
2024/3/11
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma
Cancer Research Communications
2024/2/16
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer
Cell Communication and Signaling
2024/2/15
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or …
Prostate Cancer and Prostatic Diseases
2024/2/12
Andrew B Nixon
H-Index: 22
Qian Yang
H-Index: 7
Bin Luo
H-Index: 2
Himisha Beltran
H-Index: 53
Michael J Morris
H-Index: 12
A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance …
2023/6/1
Qian Shi
H-Index: 12
Andrew B Nixon
H-Index: 22
Correlation of single-cell cytokine secretion with clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with capecitabine (C), bevacizumab (B …
2023/6/1
Lynn Lin
H-Index: 11
Andrew B Nixon
H-Index: 22
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.
2023/6/1
Helen Mackay
H-Index: 7
Andrew B Nixon
H-Index: 22
Danielle Enserro
H-Index: 21
David Bender
H-Index: 1
Daniela Matei
H-Index: 7
Circulating angiokines are associated with reverse remodeling and outcomes in chronic heart failure
Journal of Cardiac Failure
2023/6/1
Andrew B Nixon
H-Index: 22
Eric Yow
H-Index: 26
James Januzzi
H-Index: 86
G Michael Felker
H-Index: 71
Ravi Karra
H-Index: 15
4MO Homologous recombination (HR) status of platinum-responsive advanced triple-negative breast cancers (aTNBC) treated with olaparib as maintenance therapy
ESMO Open
2023/5/1
Association of inflammatory biomarkers with survival among patients with stage III colon cancer
JAMA oncology
2023/3/1
En Cheng
H-Index: 4
Qian Shi
H-Index: 12
Andrew B Nixon
H-Index: 22
Chao Ma
H-Index: 3
Pankaj Kumar
H-Index: 2
Benjamin Tan
H-Index: 5
A phase II single-arm study of the FGFR inhibitor pemigatinib in patients with metastatic colorectal cancer (mCRC) harboring FGF/FGFR alterations.
2023/2/1
Luke Wilson
H-Index: 2
Andrew B Nixon
H-Index: 22
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy
2023/12/15
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)
medRxiv
2023/12/4
Layne Rogers
H-Index: 1
William Kelly
H-Index: 11
Andrew B Nixon
H-Index: 22
Federico Innocenti
H-Index: 33
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling.
bioRxiv
2023
Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial
Communications Medicine
2023/9/8
Andrew B Nixon
H-Index: 22
High yield of pleural cell-free DNA for diagnosis of oncogenic mutations in lung adenocarcinoma
Chest
2023/7/1
Spatial genomics to reveal an immunosuppressive tumor microenvironment after chemoradiation in head and neck cancer patients.
2023/6/1
Li Fan
H-Index: 7
Andrew B Nixon
H-Index: 22
Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics.
2023/6/1
Andrew B Nixon
H-Index: 22
AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer.
2023/6/1
Andrew B Nixon
H-Index: 22
Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.
2023/6/1
Andrew B Nixon
H-Index: 22